At the Toulouse University Hospital, the consultation to free caregivers from their addictions is increasingly in demand

the essential The consultation dedicated to addiction problems among caregivers at the Toulouse University Hospital followed 66 people last year. And the demand keeps growing. It is a Toulouse initiative which brings a new stone to the building and to the observation made by the Ministry of Health: in France, caregivers are doing badly and … Read more

American Skin Association and the National Council for Skin Cancer Prevention Partner to Remind Americans to Enjoy the Sun Safely this Summer

NEW YORK, May 26, 2023 /PRNewswire/ — To encourage everyone to take small steps for sun safety, American Skin Association (ASA) announced that it has partnered with the National Council on Skin Cancer Prevention and its broad coalition of member organizations to designate the Friday before Memorial Day as “Don’t Fry Day”. This announcement comes … Read more

GomSpace Q1 2023 Report and Status Update

STOCKHOLM, May 26, 2023 /PRNewswire/ — GomSpace releases its Q1 2023, and the CEO outlines plans for bringing the company to profitability FIRST QUARTER OF 2023 Order intake was T.SEK 33,454 (41,497) Net revenues of T.SEK 78,150 are in line with Q1 2022 (78,365) Gross margin this quarter is positive 12%, compared to negative 26% for … Read more

Navamedic to own a total of 96.33 per cent of shares in Sensidose following closing of public offer

OSLO, Norway, May 26, 2023 /PRNewswire/ — Following the closing of the acceptance period in the previously announced public offer, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, will become the owner of 96.33 per cent of the share capital and votes and 93.16 per cent … Read more

FivepHusion Announces Strategic Collaboration with Treehill Partners and Syneos Health

Supporting FivepHusion’s Global Development and Commercialization Strategy SYDNEY, May 26, 2023 /PRNewswire/ — FivepHusion, an advanced clinical-stage biotechnology company, today announced its collaboration with Treehill Partners, a New York-based strategic and financial advisory firm specializing in healthcare industry transactions, and Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, to develop and bring … Read more

Des TPU de qualité médicale supérieure grâce à une usine intelligente : ICP DAS

HSINCHU, 26 mai 2023 /PRNewswire/ — La fabrication intelligente et le contrôle rigoureux des processus améliorent la qualité du TPU. ICP DAS – BMP (Polymères biomédicaux), un fournisseur de TPU (polyuréthane thermoplastique) de qualité médicale basé à Taïwan, agit comme un précurseur qui déploie des systèmes IIoT dans une usine intelligente pour maintenir la cohérence entre les lots dans … Read more

BioRay a déposé une demande d’IND pour le BRY812, un nouveau conjugué anticorps-médicament ciblant la LIV-1

SHANGHAI, 26 mai 2023 /PRNewswire/ — BioRay Pharmaceutical Co. (ci-après dénommée BioRay) a annoncé que la demande de nouveau médicament de recherche (IND) pour l’essai clinique de son produit exclusif BRY812, un nouveau conjugué anticorps-médicament (ADC) ciblant la LIV-1 humaine pour le traitement des tumeurs malignes avancées, a été acceptée par l’Administration nationale chinoise des produits médicaux (NMPA) … Read more

college blood donation

It’s a first. The Montcuq Blood Donor Committee, the French Blood Establishment and the Jean-Jacques Faurie College have joined forces to organize a blood donation within the college grounds on Friday, June 2, from 8:30 a.m. to 3 p.m. It is recommended to give priority to making an appointment beforehand by logging on to the … Read more

BioRay reicht IND-Antrag für BRY812 ein, ein neuartiges Antikörper-Wirkstoff-Konjugat, das auf LIV-1 abzielt

SHANGHAI, 26. Mai 2023 /PRNewswire/ –BioRay Pharmaceutical Co Ltd. (im Folgenden als BioRay bezeichnet) (BioRay) gab bekannt, dass der IND-Antrag (Investigational New Drug) für die klinische Erprobung des firmeneigenen BRY812, eines neuartigen Antikörper-Wirkstoff-Konjugats (ADC), das auf menschliches LIV-1 zur Behandlung fortgeschrittener bösartiger Tumore abzielt, von der China National Medical Products Administration (NMPA) angenommen wurde (Zulassungsnummer … Read more

A paraplegic man walks again thanks to thought

the essential Gert-Jan Oskam, paraplegic for 12 years, managed to walk again thanks to a technology that transforms “thought into action”. Explanations. It is a world first. Gert-Jan Oskam, a 40-year-old Dutchman, was able to walk 12 again after a bicycle accident that left him paraplegic. He has regained control of his legs and sets … Read more